DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing Wnt/β-catenin signaling DOI Creative Commons
Qingqing Liu,

Jing Chen,

Tao Ma

et al.

Scientific Reports, Journal Year: 2024, Volume and Issue: 14(1)

Published: April 24, 2024

Liver fibrosis, as a consequence of chronic liver disease, involves the activation hepatic stellate cell (HSC) caused by various injuries. Emerging evidence suggests that HSC during an inflammatory state can lead to abnormal accumulation extracellular matrix (ECM). Investigating novel strategies inhibit and proliferation holds significant importance for treatment fibrosis. As member doublecortin domain-containing family, domain containing 2 (DCDC2) mutations neonatal sclerosing cholangitis, but its involvement in fibrosis remains unclear. Therefore, this study aims elucidate role DCDC2 Our findings revealed reduction expression both human fibrotic tissues carbon tetrachloride (CCl

Language: Английский

Macrophage Polarization and Its Role in Liver Disease DOI Creative Commons
Cheng Wang, Cheng Ma, Lihong Gong

et al.

Frontiers in Immunology, Journal Year: 2021, Volume and Issue: 12

Published: Dec. 14, 2021

Macrophages are important immune cells in innate immunity, and have remarkable heterogeneity polarization. Under pathological conditions, addition to the resident macrophages, other macrophages also recruited diseased tissues, polarize various phenotypes (mainly M1 M2) under stimulation of factors microenvironment, thus playing different roles functions. Liver diseases hepatic changes caused by a variety pathogenic (viruses, alcohol, drugs, etc.), including acute liver injury, viral hepatitis, alcoholic disease, metabolic-associated fatty fibrosis, hepatocellular carcinoma. Recent studies shown that macrophage polarization plays an role initiation development diseases. However, because both pathogenesis complex, mechanism need be further clarified. Therefore, origin mechanisms reviewed first this paper. It is found involves several molecular mechanisms, mainly TLR4/NF-κB, JAK/STATs, TGF-β/Smads, PPARγ, Notch, miRNA signaling pathways. In addition, paper expounds diseases, which aims provide references for research contributing therapeutic strategy ameliorating modulating

Language: Английский

Citations

376

Hexokinase 2-mediated gene expression via histone lactylation is required for hepatic stellate cell activation and liver fibrosis DOI Creative Commons

Hyunsoo Rho,

Alexander R. Terry, Constantinos Chronis

et al.

Cell Metabolism, Journal Year: 2023, Volume and Issue: 35(8), P. 1406 - 1423.e8

Published: July 17, 2023

Language: Английский

Citations

127

Salvianolic acid B attenuates liver fibrosis by targeting Ecm1 and inhibiting hepatocyte ferroptosis DOI Creative Commons
Yadong Fu, Xiaoxi Zhou, Lin Wang

et al.

Redox Biology, Journal Year: 2024, Volume and Issue: 69, P. 103029 - 103029

Published: Jan. 4, 2024

Hepatocyte ferroptosis promotes the pathogenesis and progression of liver fibrosis. Salvianolic acid B (Sal B) exerts antifibrotic effects. However, pharmacological mechanism target has not yet been fully elucidated. In this study, fibrosis was induced by CCl4 in wild-type mice hepatocyte-specific extracellular matrix protein 1 (Ecm1)-deficient mice, which were separately treated with Sal B, ferrostatin-1, sorafenib or cilengitide. Erastin- CCl4-induced hepatocyte models without Ecm1 gene knockdown evaluated vitro. Subsequently, interaction between xCT binding kinetics determined. We found that significantly attenuated mice. deletion hepatocytes abolished effect B. Mechanistically, protected against upregulating Ecm1. Further research revealed as a direct for treating Interestingly, interacted to regulate ferroptosis. vitro treatment, abrogated after LO2 cells. Therefore, alleviates targeting up-regulation inhibiting The regulates

Language: Английский

Citations

27

Kinsenoside attenuates liver fibro-inflammation by suppressing dendritic cells via the PI3K-AKT-FoxO1 pathway DOI Creative Commons
Ming Xiang, Tingting Liu, Cheng Tian

et al.

Pharmacological Research, Journal Year: 2022, Volume and Issue: 177, P. 106092 - 106092

Published: Jan. 21, 2022

Language: Английский

Citations

57

Mesenchymal stem cell homing to improve therapeutic efficacy in liver disease DOI Creative Commons
Mengqin Yuan,

Xue Hu,

Lichao Yao

et al.

Stem Cell Research & Therapy, Journal Year: 2022, Volume and Issue: 13(1)

Published: May 3, 2022

Abstract Mesenchymal stem cell (MSC) transplantation, as an alternative strategy to orthotopic liver has been evaluated for treating end-stage disease. Although the therapeutic mechanism of MSC transplantation remains unclear, accumulating evidence demonstrated that MSCs can regenerate tissues and self-renew repair through differentiation into hepatocyte-like cells, immune regulation, anti-fibrotic mechanisms. Multiple clinical trials have confirmed restores function alleviates damage. A sufficient number must be home target after administration successful application. However, inefficient homing systemic is a major limitation in therapy. Here, we review mechanisms application status treatment disease comprehensively summarize molecular homing, various strategies promoting improve

Language: Английский

Citations

55

Extracellular Matrix Dynamics as an Emerging yet Understudied Hallmark of Aging and Longevity DOI Creative Commons
Cyril Statzer,

Ji Young Cecilia Park,

Collin Y. Ewald

et al.

Aging and Disease, Journal Year: 2023, Volume and Issue: 14(3), P. 670 - 670

Published: Jan. 1, 2023

The biomechanical properties of extracellular matrices (ECM) and their consequences for cellular homeostasis have recently emerged as a driver aging. Here we review the age-dependent deterioration ECM in context our current understanding aging processes. We discuss reciprocal interactions longevity interventions with remodeling. And relevance dynamics captured by matrisome matreotypes associated health, disease, longevity. Furthermore, highlight that many established compounds promote homeostasis. A large body evidence to qualify hallmark is emerging, data invertebrates promising. However, direct experimental proof activating sufficient slow mammals lacking. conclude further research required anticipate conceptual framework biomechanics will provide new strategies health during

Language: Английский

Citations

40

The role of altered lipid composition and distribution in liver fibrosis revealed by multimodal nonlinear optical microscopy DOI Creative Commons
Hao Jia, Juan Liu, Tinghe Fang

et al.

Science Advances, Journal Year: 2023, Volume and Issue: 9(2)

Published: Jan. 13, 2023

Intracellular lipid accumulation is commonly seen in fibrotic livers, but its exact role liver fibrosis remains elusive. Here, we established a multimodal nonlinear optical microscopy to quantitatively map distribution of biomolecules livers. Our data revealed that unsaturated triglycerides were predominantly accumulated central vein area during not portal area. Moreover, the homeostasis was remarkably dysregulated late-stage compared early-stage fibrosis, including increased with decreased unsaturation degree and membrane fluidity. Such alterations likely due up-regulated lipogenesis, desaturation, peroxidation, which consequently led endoplasmic reticulum stress cell death. Inspiringly, injured hepatocyte could be rescued by remodeling via either supply fatty acids or enhancement Collectively, our study improves current understanding open opportunities for treatment.

Language: Английский

Citations

30

Structural characteristics of a novel Bletilla striata polysaccharide and its activities for the alleviation of liver fibrosis DOI

Guanghui Jiang,

Bulei Wang,

Yuwen Wang

et al.

Carbohydrate Polymers, Journal Year: 2023, Volume and Issue: 313, P. 120781 - 120781

Published: March 9, 2023

Language: Английский

Citations

29

Exosomes in liver fibrosis: The role of modulating hepatic stellate cells and immune cells, and prospects for clinical applications DOI Creative Commons
Yufei Liu,

Yuhong Zheng,

Yang Yang

et al.

Frontiers in Immunology, Journal Year: 2023, Volume and Issue: 14

Published: March 20, 2023

Liver fibrosis is a global health problem caused by chronic liver injury resulting from various factors. Hepatic stellate cells (HSCs) have been found to play major role in fibrosis, and pathological stimuli lead their transdifferentiation into myofibroblasts. Complex multidirectional interactions between HSCs, immune cells, cytokines are also critical for the progression of fibrosis. Despite advances treatments they do not meet current medical needs. Exosomes extracellular vesicles 30-150 nm diameter capable intercellular transport molecules such as lipids, proteins nucleic acids. As an essential mediator communication, exosomes involved physiological processes many diseases. In pathogenesis mainly regulating activation HSCs interaction cells. Serum-derived promising biomarkers therapeutic potential derived mesenchymal stem other exhibit anti-liver effects. Moreover, may serve targets hold promise becoming drug carriers treatment.

Language: Английский

Citations

28

Liver fibrosis therapy based on biomimetic nanoparticles which deplete activated hepatic stellate cells DOI
Shenglong Xia,

Zimo Liu,

Jieru Cai

et al.

Journal of Controlled Release, Journal Year: 2023, Volume and Issue: 355, P. 54 - 67

Published: Feb. 1, 2023

Language: Английский

Citations

26